A review on triple-negative breast cancer and its potential treatment

A review on triple-negative breast cancer and its potential treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Opis bibliograficzny
1. autor:	Niasa, Jannatul Ferdous
Kolejni autorzy:	Chowdhury, Namara Mariam
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2023
Hasła przedmiotowe:	TNBC HER-2 receptors Anti-cancer therapeutics Signaling pathways Breast > Cancer > Patients Breast > Cancer > Treatment
Dostęp online:	http://hdl.handle.net/10361/17766

Podobne zapisy

Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Wydane: (2022)

Recent advancement on breast cancer detection and treatment
od: Rahman, Sanjida
Wydane: (2023)

Natural products and their combinatory effects in breast cancer treatment
od: Siddique, Md. Ayman
Wydane: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
od: Chakraborty, Anuradha
Wydane: (2024)

Breast cancer awareness seminars
od: Anwer Khan Modern Medical College
Wydane: (2016)

The impact of breast cancer on women’s lives in Bangladesh
od: Mobashera, Tayeeba Tum
Wydane: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
od: Akter, Honufa
Wydane: (2024)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
od: Parvin, Salma, i wsp.
Wydane: (2016)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
od: Raihan, Dilraj
Wydane: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Wydane: (2024)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
od: Shobnam, Sohana
Wydane: (2024)

Breast cancer therapy through Liposomal drug delivery system
od: Ome, Nusrat Jahan
Wydane: (2024)

Machine learning as an indicator for breast cancer prediction
od: Shadman, Tahsin Mohammed, i wsp.
Wydane: (2019)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
od: Araf, Faiaz Fahim
Wydane: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
od: Iqbal, Mohammad Shamim, i wsp.
Wydane: (2017)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
od: Mirza, Maisa Tasnim
Wydane: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
od: Khan, Rezia Nowrin
Wydane: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
od: Nuha, Nabiha Tahsin
Wydane: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
od: Lamia
Wydane: (2020)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
od: Oishy, Jannatun Noor
Wydane: (2024)

Early detection of breast cancer using machine learning
od: Fuad, Wasi Mohammad
Wydane: (2019)

Breast cancer in South Asia: a Bangladeshi perspective
od: Hossain, Mohammad Sorowar, i wsp.
Wydane: (2017)

A review on potential of PARP inhibitors in the treatment of prostate cancer
od: Islam, Saidul
Wydane: (2022)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
od: Rahman, Qazi Ashrafur
Wydane: (2018)

Breast cancer prediction using different machine learning models
od: Khandker Al- Muhaimin, i wsp.
Wydane: (2020)

Current practice and approaches of immunotherapy in Cancer treatment
od: Khondokar, Faiza
Wydane: (2022)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
od: Hasan, Sakib
Wydane: (2024)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
od: Karim, Azrin
Wydane: (2024)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
od: Muntaha, Habibatul
Wydane: (2023)

Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Wydane: (2021)

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Wydane: (2023)

Role of statins as antagonists of SPARC in gastric cancer
od: Shahmat, Rad
Wydane: (2019)

Targeting BRAFV600E in the treatment of CRC
od: Roja, Mashwiyat Samrin
Wydane: (2024)

Stem cells as therapeutic carrier in cancer treatment
od: Anika, Mysha Yeasmin
Wydane: (2022)

Microneedles in pain management of Cancer
od: Islam, Shafiqul
Wydane: (2022)

A systematic review on the comparison of FOLFIRI and FOLFOX based chemotherapies in the treatment of metastatic colorectal Cancer
od: Islam, Nurjahan
Wydane: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
od: Hasan, Amit
Wydane: (2024)

A comprehensive review on drug repurposing in cancer treatment
od: Sarkar, Onusree
Wydane: (2024)

Bioinformatics Analysis Reveals miR-98-5p as a potential Inhibitor of Tumor cell proliferation and metastasis in Colorectal Cancer by targeting the FZD3 receptor of the Wnt signaling pathway
od: Kenneth, Mutebi John
Wydane: (2022)

Machine learning In breast cancer prognosis and prediction
od: Chowdhury, Shah Abul Hasnat, i wsp.
Wydane: (2023)